News for Achaogen, Inc. (AKAOQ)

The global urinary tract infections therapeutics market size was valued at USD 8.92 billion in 2022. It is estimated to reach an expected value of USD...

Visiongain has published a new report entitled Biodefence Market 2023-2033. It includes profiles of Biodefence Market and Forecasts, Market Segment by Size...

/PRNewswire/ -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...

Visiongain has published a new report entitled Biodefence Market 2023-2033. It includes profiles of Biodefence Market and Forecasts, Market Segment by Size...

GRX’s major investments generated mixed returns over the past 5 years. See why the fund seems to be a good investment, especially for income-seeking investors.

Read Financial Review: 23andMe (NASDAQ:ME) and Achaogen (OTCMKTS:AKAOQ) at ETF Daily News

John W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair Helen S. Kim Named Lead...

/PRNewswire/ -- The

The global urinary tract infection treatment market is projected to amass a large amount of revenues in the coming years. The healthcare industry has shown a